Search
for

    Glossary Vemurafenib

    medication treats melanoma with BRAF gene mutation

    Vemurafenib is a medication used to treat certain types of cancer, specifically melanoma with a mutation in the BRAF gene. It works by inhibiting the activity of the mutated BRAF protein, which helps slow down or stop the growth of cancer cells.

    Sort by

    Research 30 of 105

    1. RASopathic Skin Eruptions during Vemurafenib Therapy PLoS ONE · 2013 · 82 citations
    2. RASopathic alopecia: Hair changes associated with vemurafenib therapy Journal of The American Academy of Dermatology · 2015 · 21 citations
    3. Vemurafenib-induced pityriasis amiantacea: a case report Cutaneous and ocular toxicology · 2015 · 9 citations
    4. Correction: RASopathic Skin Eruptions during Vemurafenib Therapy PLoS ONE · 2013 · 4 citations
    5. Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma 2016 · 32 citations
    6. Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients. Journal of the European Academy of Dermatology and Venereology · 2014 · 31 citations
    7. Cutaneous toxicities of new treatments for melanoma Clinical & Translational Oncology · 2018 · 25 citations
    8. The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma Current Dermatology Reports · 2013 · 6 citations
    9. Wound healing with topical BRAF inhibitor therapy in a diabetic model suggests tissue regenerative effects PLOS ONE · 2021 · 3 citations
    10. 554 Repurposing a clinical antimalarial for the therapeutic induction of lethal ER stress targeting BRAF-kinase inhibitor-resistant malignant melanoma Journal of Investigative Dermatology · 2016
    11. 696 MEK and BRAF inhibitors augment the production and accumulation of sebum in hamster sebocytes Journal of Investigative Dermatology · 2016
    12. Targeted therapy in melanoma Clinics in Dermatology · 2013 · 21 citations
    13. Updates from the British Association of Dermatologists 91st Annual Meeting, 5-7 July 2011, London, U.K. British Journal of Dermatology · 2012 · 1 citations
    14. Biological therapy in the treatment of melanoma Journal of Mind and Medical Sciences · 2018 · 3 citations
    15. 559 Visualization of sweat suppression following botulinum toxin A by soluble microneedle arrays Journal of Investigative Dermatology · 2016
    16. Management of Toxicities of Targeted Therapies Elsevier eBooks · 2018 · 2 citations
    17. Skin Adipocyte Stem Cell Self-Renewal Is Regulated by a PDGFA/AKT-Signaling Axis Cell Stem Cell · 2016 · 106 citations
    18. Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer Journal of the American Academy of Dermatology · 2014 · 88 citations
    19. Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment Theranostics · 2022 · 67 citations
    20. Alopecia in patients treated with molecularly targeted anticancer therapies Annals of Oncology · 2015 · 44 citations
    21. Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review International Journal of Dermatology · 2018 · 34 citations
    22. Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology Clinical & Translational Oncology · 2018 · 26 citations
    23. Alopecia in Association with Malignancy: A Review American Journal of Clinical Dermatology · 2018 · 26 citations
    24. Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology Anais Brasileiros de Dermatologia · 2020 · 22 citations
    25. Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study Archives of Cardiovascular Diseases · 2019 · 17 citations
    26. Dynamic Trichoscopy JAMA Dermatology · 2018 · 14 citations
    27. New small molecules in dermatology: for the autoimmunity, inflammation and beyond Inflammation Research · 2023 · 9 citations
    28. Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil Strahlentherapie und Onkologie · 2021 · 9 citations
    29. Malignant epithelial tumors: Part II. Therapy and prevention Journal der Deutschen Dermatologischen Gesellschaft · 2013 · 5 citations
    30. Cutaneous Side Effects of Chemotherapy and Radiotherapy 2016 · 2 citations